Home News Alzheimer’s Therapy Drug: Should We Pay $56,000 to Slow the Loss of...

Alzheimer’s Therapy Drug: Should We Pay $56,000 to Slow the Loss of Mom’s Mind?

June 23, 2021

Aduhelm sparks controversy as a therapy drug for Alzheimer's patients that attacks amyloid plaques in the brain, and slows the decline of memory and problem-…

ALL CONTENT ON 'FINANCIALSURVIVALNETWORK.COM' IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY. 'FINANCIALSURVIVALNETWORK.COM' ASSUMES ALL INFORMATION TO BE TRUTHFUL AND RELIABLE; HOWEVER, THE CONTENT ON THIS SITE IS PROVIDED WITHOUT ANY WARRANTY, EXPRESS OR IMPLIED. NO MATERIAL HERE CONSTITUTES "INVESTMENT ADVICE" NOR IS IT A RECOMMENDATION TO BUY OR SELL ANY FINANCIAL INSTRUMENT, INCLUDING BUT NOT LIMITED TO STOCKS, COMMODITIES, OPTIONS, BONDS, PRECIOUS METALS, OR FUTURES. ACTIONS YOU UNDERTAKE AS A CONSEQUENCE OF ANY ANALYSIS, OPINION OR ADVERTISEMENT ON THIS SITE ARE YOUR SOLE RESPONSIBILITY. THANK YOU.